Instytut Hematologii i Transfuzjologi
In research, Instytut Hematologii i Transfuzjologi stands highest in Medicine (#7,580 of 10,443 worldwide) and Health Sciences (#9,366 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology — Hematology is 61.9× its share of world research.
- World rank, 2022–2025
- #17,382 of 28,054 · #19,897 all time
- Rank in Poland
- #189 of 318
- Research works
- 1.5k ▼ 34% vs 2013–17
- Citations
- 7.8k 5.2 per fractional work
- Top-10% rate
- 9.8% record average 16.5%
- Open access
- 27% world 28%
What is Instytut Hematologii i Transfuzjologi known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,580 of 10,443 | 11.1% | 85 | #9575 | |
| Health SciencesDomain | #9,366 of 11,982 | 11.4% | 87 | #12193 |
Each strip is that field’s whole ranked pool, with the notch where Instytut Hematologii i Transfuzjologi sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Instytut Hematologii i Transfuzjologi specialise in?
Where its research is concentrated relative to its size: Hematology takes 61.9× the share of its output that it takes of world research.
- HematologySubfield · 25.0 works62×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.5×. Every wedge is a field page.
- Immunology and Microbiology 4.5×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Business, Management and Accounting 1.4×
- Energy 0.8×
- Dentistry 0.5×
- Social Sciences 0.4×
- Health Professions 0.4×
- Nursing 0.3×
- Economics, Econometrics and Finance 0.3×
- Chemistry 0.3×
- Neuroscience 0.3×
- Decision Sciences 0.3×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Veterinary 0.2×
- Arts and Humanities 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
- Environmental Science 0.0×
Who are the top researchers at Instytut Hematologii i Transfuzjologi?
Ranked on the composite score, Krzysztof Brzózka, Przemysław Juszczyński and Jerzy Kościelak lead among researchers whose main affiliation is Instytut Hematologii i Transfuzjologi.
- 1 Krzysztof Brzózka Poland · #71,883 worldwide 324 citations · 28 works
- 2 Przemysław Juszczyński Poland · #343,648 worldwide 92 citations · 26 works
- 3 Jerzy Kościelak Poland · #611,130 worldwide 64 citations · 29 works
- 4 Piotr Grabarczyk Poland · #630,958 worldwide 5 citations · 24 works
- 5 Michał Michalik Poland · #647,665 worldwide 0 citations · 18 works
- 6 S Łopaciuk Poland · #677,144 worldwide 27 citations · 31 works
- 7 Ewa Lech‐Marańda Poland · #738,300 worldwide 82 citations · 65 works
- 8 Mirosław Majewski Poland · #762,020 worldwide 63 citations · 16 works
- 9 Krzysztof Jamroziak Poland · #813,512 worldwide 72 citations · 40 works
- 10 Krzysztof Warzocha Poland · #906,056 worldwide 81 citations · 83 works
Which keywords describe research at Instytut Hematologii i Transfuzjologi?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Rituximab, Prophylaxis, Hematopoietic Stem Cells, Risk Factors, Minimal Residual Disease, Therapeutic Targets and Chronic Lymphocytic Leukemia.
- Liver Disease
- International Myeloma Working Group
- Constitutional Law
- Anemia
- PET Imaging
- Thrombosis
- BCR-ABL
- Cancer Therapy
- Immune Response
- Blood Donation
- Hemophilia
- Mutation
- Gene Therapy
- Acute Myeloid Leukemia
- Blood Transfusion
- Genomic Aberrations
- Therapeutic Targets
- Hematopoietic Stem Cells
- Risk Factors
- Rituximab
- Prognostic Factors
- Inflammation
- Prophylaxis
- Minimal Residual Disease
- Chronic Lymphocytic Leukemia
- Treatment
- AML
- Inhibitors
- Efficacy
- Factor VIII
- Recombinant Factor VIIa
- Supply Chain Management
- Proteasome Inhibitors
- Hemostasis
- Imatinib
- Lymphoma
- Public Administration
- Antiviral Therapy
- Diagnosis Criteria
- Legal Reform
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors17▲ 28×9 topics
- Rituximab9▲ 47×4 topics
- Inflammation8▲ 2.9×22 topics
- Risk Factors8▲ 5.5×7 topics
- Prophylaxis7▲ 43×3 topics
- Hematopoietic Stem Cells7▲ 59×3 topics
- Minimal Residual Disease7▲ 72×2 topics
- Therapeutic Targets7▲ 32×4 topics
- Chronic Lymphocytic Leukemia6▲ 101×1 topic
- Genomic Aberrations6▲ 101×1 topic
- Treatment6▲ 3.6×10 topics
- Blood Transfusion6▲ 97×2 topics
- AML5▲ 82×1 topic
- Acute Myeloid Leukemia5▲ 82×1 topic
- Inhibitors5▲ 94×2 topics
- Gene Therapy5▲ 20×3 topics
- Efficacy5▲ 51×2 topics
- Mutation5▲ 20×3 topics
- Factor VIII5▲ 244×1 topic
- Hemophilia5▲ 244×1 topic
- Recombinant Factor VIIa5▲ 79×2 topics
- Blood Donation5▲ 209×1 topic
- Supply Chain Management5▲ 3.7×1 topic
- Immune Response4▲ 5.9×8 topics
- Proteasome Inhibitors4▲ 48×2 topics
- Cancer Therapy4▲ 5.8×11 topics
- Hemostasis4▲ 34×3 topics
- BCR-ABL4▲ 121×1 topic
- Imatinib4▲ 121×1 topic
- Thrombosis4▲ 12×6 topics
- Lymphoma4▲ 19×2 topics
- PET Imaging4▲ 17×3 topics
- Public Administration4▲ 32×2 topics
- Anemia4▲ 29×4 topics
- Antiviral Therapy4▲ 27×3 topics
- Constitutional Law4▲ 20×1 topic
- Diagnosis Criteria4▲ 74×1 topic
- International Myeloma Working Group4▲ 74×1 topic
- Legal Reform4▲ 83×1 topic
- Liver Disease3▲ 27×2 topics
Which research topics does Instytut Hematologii i Transfuzjologi publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Hemophilia Treatment and Research and Blood donation and transfusion practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 6 works
- 2 Acute Myeloid Leukemia Research Hematology 5 works
- 3 Hemophilia Treatment and Research Hematology 5 works
- 4 Blood donation and transfusion practices Management of Technology and Innovation 5 works
- 5 Chronic Myeloid Leukemia Treatments Hematology 4 works
- 6 Multiple Myeloma Research and Treatments Hematology 4 works
- 7 Polish Law and Legal System Political Science and International Relations 4 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 3 works
- 10 Platelet Disorders and Treatments Hematology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Instytut Hematologii i Transfuzjologi's research output changed?
Output in 2018–2022 was 34% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Warsaw
- University of Warsaw
- Polish Academy of Sciences
- Warsaw University of Technology
- Warsaw University of Life Sciences
- Medical University of Warsaw
- Institute of Physics
- Military University of Technology in Warsaw
- Cardinal Stefan Wyszynski University in Warsaw
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.